BDBM319844 3-(5-Methyl-1,3-thiazol-2-yl)-5-[(3R)-tetrahydrofuran-3-yloxy]-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide::US10174016, Example 11::US10202369, Example 11::US10472354, Example 291

SMILES C[C@@H](NC(=O)c1cc(O[C@@H]2CCOC2)cc(c1)-c1ncc(C)s1)c1cnc(nc1)C(F)(F)F

InChI Key InChIKey=GTQPEQGDLVSFJO-CXAGYDPISA-N

Data  21 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 21 hits for monomerid = 319844   

TargetP2X purinoceptor 3(Human)
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM319844(3-(5-Methyl-1,3-thiazol-2-yl)-5-[(3R)-tetrahydrofu...)
Affinity DataIC50:  8nMAssay Description:A fluorescent imaging plate reader (FLEX/FLIPR station; Molecular Devices) was used to monitor intracellular calcium levels using the calcium-chelati...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetP2X purinoceptor 3(Human)
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM319844(3-(5-Methyl-1,3-thiazol-2-yl)-5-[(3R)-tetrahydrofu...)
Affinity DataIC50:  8nMAssay Description:Antagonist activity at human P2X3R expressed in HEK293 cells assessed as reduction in alphabeta-MeATP-induced intracellular Ca2+ influx pretreated wi...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetP2X purinoceptor 3(Human)
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM319844(3-(5-Methyl-1,3-thiazol-2-yl)-5-[(3R)-tetrahydrofu...)
Affinity DataIC50:  8nMAssay Description:A fluorescent imaging plate reader (FLEX/FLIPR station; Molecular Devices) was used to monitor intracellular calcium levels using the calcium-chelati...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetP2X purinoceptor 2(Human)
Beyer Aktiengesellschaft

US Patent
LigandPNGBDBM319844(3-(5-Methyl-1,3-thiazol-2-yl)-5-[(3R)-tetrahydrofu...)
Affinity DataIC50:  163nMAssay Description:A fluorescent imaging plate reader (FLEX/FLIPR station; Molecular Devices) was used to monitor intracellular calcium levels using the calcium-chelati...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetCytochrome P450 1A2(Human)
Beyer Aktiengesellschaft

US Patent
LigandPNGBDBM319844(3-(5-Methyl-1,3-thiazol-2-yl)-5-[(3R)-tetrahydrofu...)
Affinity DataIC50: >2.00E+4nMAssay Description:Use of in vitro assays to evaluate the inhibition potential of new drug candidates towards CYP-mediated metabolism has been shown to be effective as ...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetCytochrome P450 2C8(Human)
Beyer Aktiengesellschaft

US Patent
LigandPNGBDBM319844(3-(5-Methyl-1,3-thiazol-2-yl)-5-[(3R)-tetrahydrofu...)
Affinity DataIC50: >2.00E+4nMAssay Description:Use of in vitro assays to evaluate the inhibition potential of new drug candidates towards CYP-mediated metabolism has been shown to be effective as ...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetCytochrome P450 2C9(Human)
Beyer Aktiengesellschaft

US Patent
LigandPNGBDBM319844(3-(5-Methyl-1,3-thiazol-2-yl)-5-[(3R)-tetrahydrofu...)
Affinity DataIC50: >2.00E+4nMAssay Description:Use of in vitro assays to evaluate the inhibition potential of new drug candidates towards CYP-mediated metabolism has been shown to be effective as ...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetCytochrome P450 2D6(Human)
Beyer Aktiengesellschaft

US Patent
LigandPNGBDBM319844(3-(5-Methyl-1,3-thiazol-2-yl)-5-[(3R)-tetrahydrofu...)
Affinity DataIC50: >2.00E+4nMAssay Description:Use of in vitro assays to evaluate the inhibition potential of new drug candidates towards CYP-mediated metabolism has been shown to be effective as ...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetCytochrome P450 3A4(Human)
Beyer Aktiengesellschaft

US Patent
LigandPNGBDBM319844(3-(5-Methyl-1,3-thiazol-2-yl)-5-[(3R)-tetrahydrofu...)
Affinity DataIC50: >2.00E+4nMAssay Description:Use of in vitro assays to evaluate the inhibition potential of new drug candidates towards CYP-mediated metabolism has been shown to be effective as ...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetP2X purinoceptor 3(Human)
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM319844(3-(5-Methyl-1,3-thiazol-2-yl)-5-[(3R)-tetrahydrofu...)
Affinity DataIC50:  8nMAssay Description:A fluorescent imaging plate reader (FLEX/FLIPR station; Molecular Devices) was used to monitor intracellular calcium levels using the calcium-chelati...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetP2X purinoceptor 2/3(Human)
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM319844(3-(5-Methyl-1,3-thiazol-2-yl)-5-[(3R)-tetrahydrofu...)
Affinity DataIC50:  163nMAssay Description:A fluorescent imaging plate reader (FLEX/FLIPR station; Molecular Devices) was used to monitor intracellular calcium levels using the calcium-chelati...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetCytochrome P450 1A2(Human)
Beyer Aktiengesellschaft

US Patent
LigandPNGBDBM319844(3-(5-Methyl-1,3-thiazol-2-yl)-5-[(3R)-tetrahydrofu...)
Affinity DataIC50: >2.00E+4nMAssay Description:Human liver microsomes (pooled, >30 male and female donors) were incubated with individual CYP isoform-selective standard probes (phenacetin for CYP1...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetCytochrome P450 2C8(Human)
Beyer Aktiengesellschaft

US Patent
LigandPNGBDBM319844(3-(5-Methyl-1,3-thiazol-2-yl)-5-[(3R)-tetrahydrofu...)
Affinity DataIC50: >2.00E+4nMAssay Description:Human liver microsomes (pooled, >30 male and female donors) were incubated with individual CYP isoform-selective standard probes (phenacetin for CYP1...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetCytochrome P450 2C9(Human)
Beyer Aktiengesellschaft

US Patent
LigandPNGBDBM319844(3-(5-Methyl-1,3-thiazol-2-yl)-5-[(3R)-tetrahydrofu...)
Affinity DataIC50: >2.00E+4nMAssay Description:Human liver microsomes (pooled, >30 male and female donors) were incubated with individual CYP isoform-selective standard probes (phenacetin for CYP1...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetCytochrome P450 2D6(Human)
Beyer Aktiengesellschaft

US Patent
LigandPNGBDBM319844(3-(5-Methyl-1,3-thiazol-2-yl)-5-[(3R)-tetrahydrofu...)
Affinity DataIC50: >2.00E+4nMAssay Description:Human liver microsomes (pooled, >30 male and female donors) were incubated with individual CYP isoform-selective standard probes (phenacetin for CYP1...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetCytochrome P450 3A4(Human)
Beyer Aktiengesellschaft

US Patent
LigandPNGBDBM319844(3-(5-Methyl-1,3-thiazol-2-yl)-5-[(3R)-tetrahydrofu...)
Affinity DataIC50: >2.00E+4nMAssay Description:Human liver microsomes (pooled, >30 male and female donors) were incubated with individual CYP isoform-selective standard probes (phenacetin for CYP1...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetP2X purinoceptor 3(Human)
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM319844(3-(5-Methyl-1,3-thiazol-2-yl)-5-[(3R)-tetrahydrofu...)
Affinity DataIC50:  8nMAssay Description:A fluorescent imaging plate reader (FILEX/FLIPR station; Molecular Devices) was used to monitor intracellular calcium levels using the calcium-chelat...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetP2X purinoceptor 2/3(Human)
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM319844(3-(5-Methyl-1,3-thiazol-2-yl)-5-[(3R)-tetrahydrofu...)
Affinity DataIC50:  163nMAssay Description:A fluorescent imaging plate reader (FILEX/FLIPR station; Molecular Devices) was used to monitor intracellular calcium levels using the calcium-chelat...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetP2X purinoceptor 3(Human)
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM319844(3-(5-Methyl-1,3-thiazol-2-yl)-5-[(3R)-tetrahydrofu...)
Affinity DataIC50:  1.32E+3nMAssay Description:A fluorescent imaging plate reader (FILEX/FLIPR station; Molecular Devices) was used to monitor intracellular calcium levels using the calcium-chelat...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetP2X purinoceptor 2/3(Human)
Bayer Aktiengesellschaft

US Patent
LigandPNGBDBM319844(3-(5-Methyl-1,3-thiazol-2-yl)-5-[(3R)-tetrahydrofu...)
Affinity DataIC50:  1.00E+4nMAssay Description:A fluorescent imaging plate reader (FILEX/FLIPR station; Molecular Devices) was used to monitor intracellular calcium levels using the calcium-chelat...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetP2X purinoceptor 2(Human)
Beyer Aktiengesellschaft

US Patent
LigandPNGBDBM319844(3-(5-Methyl-1,3-thiazol-2-yl)-5-[(3R)-tetrahydrofu...)
Affinity DataIC50:  163nMAssay Description:A fluorescent imaging plate reader (FLEX/FLIPR station; Molecular Devices) was used to monitor intracellular calcium levels using the calcium-chelati...More data for this Ligand-Target Pair
In DepthDetails US Patent